dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ciardiello, Fortunato |
dc.contributor.author | Hirsch, Fred R. |
dc.contributor.author | Pirker, Robert |
dc.contributor.author | Valencia, Christian |
dc.contributor.author | Smit, Egbert |
dc.contributor.author | FELIP, ENRIQUETA |
dc.date.accessioned | 2024-02-05T08:50:21Z |
dc.date.available | 2024-02-05T08:50:21Z |
dc.date.issued | 2024-01 |
dc.identifier.citation | Ciardiello F, Hirsch FR, Pirker R, Felip E, Valencia C, Smit EF. The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer. Cancer Treat Rev. 2024 Jan;122:102664. |
dc.identifier.issn | 0305-7372 |
dc.identifier.uri | https://hdl.handle.net/11351/10974 |
dc.description | Anti-EGFR; Biomarcador; Inhibidor de la tirosina quinasa |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Cancer Treatment Reviews;122 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Anticossos monoclonals - Ús terapèutic |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Anomalies cromosòmiques |
dc.subject | Proteïnes quinases - Inhibidors - Ús terapèutic |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antibodies, Monoclonal |
dc.subject.mesh | Mutation |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.title | The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.dl | 001135624600001 |
dc.identifier.doi | 10.1016/j.ctrv.2023.102664 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | anticuerpos monoclonales |
dc.subject.decs | mutación |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.relation.publishversion | https://doi.org/10.1016/j.ctrv.2023.102664 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ciardiello F] Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples, Italy. [Hirsch FR] Center for Thoracic Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA. [Pirker R] Private Practice for Internal Medicine (Hemato-Oncology), Vienna, Austria. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Valencia C] EMD Serono Research & Development Institute, Inc, Billerica, MA, USA. [Smit EF] Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, the Netherlands |
dc.identifier.pmid | 38064878 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |